FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/28/2026
Back to search
Official data from USPTO
ZIMUNAV
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
07/28/2026
Trademark type
Word
Nice classes
5
Filing date
02/21/2025
Registration date
04/28/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/28/2026
Last transaction
07/28/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
IE
Examiner
O'BRIEN, JENNIFER LYNN
Law office
N30
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
G. U. (pessoa física)
Representatives
Cynthia Smuzynska Gilead Sciences, Inc.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders
Publications
History of USPTO decisions and trademark events.
19 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/28/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
04/28/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/10/2026
PUBO
PUBLISHED FOR OPPOSITION
03/10/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/04/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/17/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/03/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/03/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/03/2026
RFNT
REFUSAL PROCESSED BY IB
09/27/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/09/2025
RFRR
REFUSAL PROCESSED BY MPU
09/09/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/01/2025
CNRT
NON-FINAL ACTION WRITTEN
07/31/2025
DOCK
ASSIGNED TO EXAMINER
07/25/2025
MAFR
APPLICATION FILING RECEIPT MAILED
04/28/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/28/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/24/2025
Continuous trademark protection
Get notified about every new filing that threatens ZIMUNAV or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.